2023 - Research.com Medicine in Sweden Leader Award
His scientific interests lie mostly in Adenosine, Internal medicine, Endocrinology, Adenosine receptor and Adenosine A1 receptor. His Adenosine study integrates concerns from other disciplines, such as Caffeine, Receptor, Adenosine A2A receptor, Neuroscience and Pharmacology. His Endocrinology study typically links adjacent topics like Cerebral arteries.
His Adenosine receptor research is multidisciplinary, relying on both Purinergic receptor and Ischemia. The Adenosine A1 receptor study combines topics in areas such as Antagonist, Neurotransmission, Neuroprotection, Basal forebrain and Adenosine kinase. His studies in Purinergic signalling integrate themes in fields like Adenosine A3 receptor, G protein-coupled receptor and Class C GPCR.
Bertil B. Fredholm mainly focuses on Internal medicine, Endocrinology, Adenosine, Adenosine receptor and Adenosine A1 receptor. Many of his studies involve connections with topics such as Agonist and Endocrinology. Bertil B. Fredholm interconnects Receptor, Purinergic signalling, Neuroscience and Pharmacology in the investigation of issues within Adenosine.
His Purinergic signalling research incorporates elements of Adenosine A3 receptor and Cell biology. His work on Adenosine A2A receptor, SCH-58261 and Adenosine receptor antagonist as part of general Adenosine receptor study is frequently linked to Xanthine, bridging the gap between disciplines. His work carried out in the field of Adenosine A1 receptor brings together such families of science as Adenosine A2B receptor and Neurotransmission.
Bertil B. Fredholm mostly deals with Adenosine, Internal medicine, Endocrinology, Adenosine receptor and Receptor. The various areas that he examines in his Adenosine study include Adenosine A3 receptor, Adenine nucleotide, Adenosine A1 receptor, Neuroscience and Pharmacology. His Adenosine A1 receptor research also works with subjects such as
His study on Endocrinology is mostly dedicated to connecting different topics, such as Ghrelin. Bertil B. Fredholm has researched Adenosine receptor in several fields, including AMPA receptor, Neuroglia, Immunology and Mechanism of action. He has included themes like Molecular biology and Islet in his Receptor study.
Bertil B. Fredholm mostly deals with Adenosine, Adenosine receptor, Endocrinology, Internal medicine and Pharmacology. His Adenosine research includes elements of Adenosine A1 receptor, Caffeine, Neuroprotection, Receptor and Theophylline. His Adenosine A1 receptor research integrates issues from Adenosine A3 receptor, Adenosine A2B receptor, Purinergic signalling and Adenosine deaminase.
His Adenosine receptor study combines topics in areas such as Neuroglia, Neuroscience and Immunology. In his study, Bone remodeling, Osteoporosis, Bone density, Bone mineral and Cortical bone is strongly linked to Osteoclast, which falls under the umbrella field of Endocrinology. His Internal medicine study incorporates themes from Sleep onset and Non-rapid eye movement sleep.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Bertil B. Fredholm;Adriaan P. IJzerman;Kenneth A. Jacobson;Karl-Norbert Klotz.
Pharmacological Reviews (2001)
Actions of Caffeine in the Brain with Special Reference to Factors That Contribute to Its Widespread Use
Bertil B. Fredholm;Karl Bättig;Janet Holmén;Astrid Nehlig.
Pharmacological Reviews (1999)
NOMENCLATURE AND CLASSIFICATION OF PURINOCEPTORS
B B Fredholm;M P Abbracchio;G Burnstock;J W Daly.
Pharmacological Reviews (1994)
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
Bertil B. Fredholm;Adriaan P. IJzerman;Kenneth A. Jacobson;Joel Linden.
Pharmacological Reviews (2011)
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Sergi Ferré;Kjell Fuxe;Bertil B. Fredholm;Micaela Morelli.
Trends in Neurosciences (1997)
How does adenosine inhibit transmitter release
B.B. Fredholm;T.V. Dunwiddie.
Trends in Pharmacological Sciences (1988)
Adenosine receptors as drug targets — what are the challenges?
Jiang-Fan Chen;Holger K. Eltzschig;Bertil B. Fredholm.
Nature Reviews Drug Discovery (2013)
Adenosine and Brain Function
Bertil B Fredholm;Jiang-Fan Chen;Rodrigo A Cunha;Per Svenningsson.
International Review of Neurobiology (2005)
Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cells
K N Klotz;J Hessling;J Hegler;Christer Owman.
Naunyn-schmiedebergs Archives of Pharmacology (1997)
Adenosine, an endogenous distress signal, modulates tissue damage and repair
B B Fredholm.
Cell Death & Differentiation (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: